Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-27

Clinical Trial Update: Septorhinoplasty Post-operative Pain Control With SPG Nerve Block [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sphenopalatine ganglion (SPG) nerve block for post-operative pain control after septorhinoplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPG nerve block

Snippet

Sponsor: University of Florida | Conditions: Deviated Nasal Septum | Phase 4 | Status: COMPLETED | Results posted: 2026-04-27